Search for topics, articles, videos, research, etc...
Hit enter to search or ESC to close
Are you looking for:
MJFF Publications
Donate Now
Access Resources

MJFF Publications
1281 - 1290 of 8620 Results
Title
Year
  • Year
  • 2021
  • 2020
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • Validity and reliability of the suggested immobilization test for measurement of restless legs syndrome severity in adults with multiple sclerosis
    2021
    Summary Details
    OPEN
    Title: Validity and reliability of the suggested immobilization test for measurement of restless legs syndrome severity in adults with multiple sclerosis
    Author(s): Katie L.J. Cederberg, Arthur S. Walters, Amy W. Amara, Tiffany J. Braley, Morgan L. Schuetz, Brianna G. Mathison, Robert W. Motl
    Journal Name: Sleep Medicine
    Publisher: Elsevier BV
    Vol: 84
    Issue #:
    Start Page: 343
    End Page: 351
    Publication Date:
    Open Access(OA) Status: OPEN
    License: other-oa
    DOI - Digital Object Identifier: 10.1016/j.sleep.2021.06.005
    Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8355084
    Citation Count: 6
  • How firms undertake organizational changes to shift to more-exploratory strategies: A process perspective
    2020
    Summary Details
    OPEN
    Title: How firms undertake organizational changes to shift to more-exploratory strategies: A process perspective
    Author(s): Jane Bjørn Vedel, Olga Kokshagina
    Journal Name: Research Policy
    Publisher: Elsevier BV
    Vol: 50
    Issue #: 1
    Start Page: 104118
    End Page: 104118
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.respol.2020.104118
    Best OA location URL: https://minesparis-psl.hal.science/hal-02943926
    Citation Count: 22
  • Optimal Treatment of Depression and Anxiety in Parkinson's Disease
    2021
    Summary Details
    RESTRICTED
    Title: Optimal Treatment of Depression and Anxiety in Parkinson's Disease
    Author(s): Gregory M. Pontone, Kelly A. Mills
    Journal Name: The American Journal of Geriatric Psychiatry
    Publisher: Elsevier BV
    Vol: 29
    Issue #: 6
    Start Page: 530
    End Page: 540
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.jagp.2021.02.037
    Best OA location URL:
    Citation Count: 50
  • Olfaction, cholinergic basal forebrain degeneration, and cognition in early Parkinson disease
    2021
    Summary Details
    OPEN
    Title: Olfaction, cholinergic basal forebrain degeneration, and cognition in early Parkinson disease
    Author(s): Matthew J. Barrett, Justin M. Murphy, Jeffrey Zhang, Jamie Blair, Joseph L. Flanigan, Huma Nawaz, William Dalrymple, Scott A. Sperling, James T. Patrie, T. Jason Druzgal
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Vol: 90
    Issue #:
    Start Page: 27
    End Page: 32
    Publication Date:
    Open Access(OA) Status: OPEN
    License: other-oa
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.07.024
    Best OA location URL: https://doi.org/10.1016/j.parkreldis.2021.07.024
    Citation Count: 17
  • The Importance of Cross-Disciplinary Research: A Commentary on “Brainstem Pathologies Correlate With Depression and Psychosis in Parkinson's Disease”
    2021
    Summary Details
    RESTRICTED
    Title: The Importance of Cross-Disciplinary Research: A Commentary on “Brainstem Pathologies Correlate With Depression and Psychosis in Parkinson's Disease”
    Author(s): Ruth B. Schneider, Irene Hegeman Richard
    Journal Name: The American Journal of Geriatric Psychiatry
    Publisher: Elsevier BV
    Vol: 29
    Issue #: 9
    Start Page: 969
    End Page: 971
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.jagp.2021.01.010
    Best OA location URL:
    Citation Count: 0
  • Efficacy results of pimavanserin from a multi-center, open-label extension study in Parkinson's disease psychosis patients
    2021
    Summary Details
    OPEN
    Title: Efficacy results of pimavanserin from a multi-center, open-label extension study in Parkinson's disease psychosis patients
    Author(s): Stuart Isaacson, Clive Ballard, David Kreitzman, Bruce Coate, James C. Norton, Hubert H. Fernandez, Tihomir Ilić, Jean‐Philippe Azulay, Joaquim J. Ferreira, Victor Abler, Srdjan Stankovic
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Vol: 87
    Issue #:
    Start Page: 25
    End Page: 31
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.04.012
    Best OA location URL: http://www.prd-journal.com/article/S1353802021001450/pdf
    Citation Count: 19
  • Coincident parkinsonism and myasthenia gravis: A case series
    2021
    Summary Details
    RESTRICTED
    Title: Coincident parkinsonism and myasthenia gravis: A case series
    Author(s): Jumana Alshaikh, Kelly A. Mills
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Vol: 89
    Issue #:
    Start Page: 4
    End Page: 5
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.06.016
    Best OA location URL:
    Citation Count: 7
  • Impact of the apolipoprotein E ε4 allele on early Parkinson's disease progression
    2021
    Summary Details
    RESTRICTED
    Title: Impact of the apolipoprotein E ε4 allele on early Parkinson's disease progression
    Author(s): Ryul Kim, Sangmin Park, Dallah Yoo, Jin‐Sun Jun, Beomseok Jeon
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Vol: 83
    Issue #:
    Start Page: 66
    End Page: 70
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.01.004
    Best OA location URL:
    Citation Count: 10
  • A new CERAD total score with equally weighted z-scores and additional executive and non-amnestic „CERAD-Plus“ tests enhances cognitive diagnosis in patients with Parkinson's disease: Evidence from the LANDSCAPE study
    2021
    Summary Details
    RESTRICTED
    Title: A new CERAD total score with equally weighted z-scores and additional executive and non-amnestic „CERAD-Plus“ tests enhances cognitive diagnosis in patients with Parkinson's disease: Evidence from the LANDSCAPE study
    Author(s): Robert Lillig, Anja Ophey, Jörg B. Schulz, Kathrin Reetz, Jennifer Wojtala, Alexander Storch, Inga Liepelt‐Scarfone, Sara Becker, Daniela Berg, Monika Balzer‐Geldsetzer, Jan Kassubek, Rüdiger Hilker-Roggendorf, Karsten Witt, Brit Mollenhauer, Claudia Trenkwalder, Sandra Roeske, Hans‐Ulrich Wïttchen, Oliver Riedel, Richard Dodel, Elke Kalbe
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Vol: 90
    Issue #:
    Start Page: 90
    End Page: 97
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.07.034
    Best OA location URL:
    Citation Count: 13
  • North American survey on impact of the COVID-19 pandemic shutdown on DBS care
    2021
    Summary Details
    OPEN
    Title: North American survey on impact of the COVID-19 pandemic shutdown on DBS care
    Author(s): Mustafa Siddiqui, Joohi Jimenez‐Shahed, Zoltán Mari, Benjamin L. Walter, Sol De Jesus, Fedor Panov, Jason M. Schwalb, Michele K. York, Harini Sarva, John M. Bertoni, Neepa Patel, Lin Zhang, James McInerney, Joshua M. Rosenow
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Vol: 92
    Issue #:
    Start Page: 41
    End Page: 45
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.10.011
    Best OA location URL: http://www.prd-journal.com/article/S1353802021003667/pdf
    Citation Count: 7
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.